Deepcell

Deepcell is a biotechnology company based in Menlo Park, California, pioneering the integration of artificial intelligence (AI) with microfluidics and high-resolution imaging to transform single-cell analysis. Founded in 2017 by Maddison Masaeli, Ph.D., Euan Ashley, M.D., Ph.D., and Mahyar Salek, Ph.D., Deepcell emerged from research at Stanford University with the mission to revolutionize cell biology through AI-driven morphological analysis.

Category
Biotechnology
Industry
Healthcare, AI
Business Model
B2B
Funding Round
Series B
Valuation Estimate
$100M - $1B
HQ Country
USA
HQ City
San Francisco, USA